ADVANCED ENZYME TECHNOLOGIES
Back to All Ratios
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 13.38 | 18.30 | 22.57 | 18.65 | 19.86 |
What is the latest Price to Cash Earnings (PCE) ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 13.38 |
| Mar2025 | 18.30 |
| Mar2024 | 22.57 |
| Mar2023 | 18.65 |
| Mar2022 | 19.86 |
How is Price to Cash Earnings (PCE) of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 13.38 | -26.89 | |
| Mar2025 | 18.3 | -18.92 | |
| Mar2024 | 22.57 | 21.02 | |
| Mar2023 | 18.65 | -6.09 | |
| Mar2022 | 19.86 | - | |
Other Financial Ratios of ADVANCED ENZYME TECHNOLOGIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹2,940.0 Cr | -1.7% | -8.9% | -14.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | -1.7% |
-8.9% |
-14.5% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses